Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04023695 · ClinicalTrials.gov registry record · Phase 4
Trigger Finger Corticosteroid Injection With and Without Local Anesthetic
A Phase 4 study, sponsored by Vanderbilt University Medical Center.
- Completed
- Registry status
- Phase 4
- Development phase
- 110
- Enrollment target
NCT04023695: Completed Phase 4 study, sponsored by Vanderbilt University Medical Center.
NCT04023695 is a Phase 4 study that has completed, run by Vanderbilt University Medical Center. The registered enrollment target is 110 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (79% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04023695, a Phase 4 study, has completed, sponsored by Vanderbilt University Medical Center.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 110 participants
- Enrollment target
Study Summary
Steroid injection is the first line treatment for trigger finger. Steroid injection is sometimes mixed with a local anesthetic.
Primary Outcome
Assessed using the visual analog scale (0-10 scale). Zero indicates no pain, 10 indicates worst pain ever
Interventions
- DRUG Corticosteroid with lidocaine with epinephrine
- DRUG Corticosteroid with normal saline
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 110 participants |
| Start Date | 2017-10-01 |
| Est. Completion | 2018-08-30 |
| Phase | Phase 4 |
What the finished NCT04023695 record still lists
NCT04023695 is an interventional study that assigns participants to a tested intervention. The registered 110 participants enrollment target is mid-sized for trials with a published cap, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (79% lower).
The record links to 0 conditions, and to 2 interventions - of which Corticosteroid with lidocaine with epinephrine is the first listed.
NCT04023695 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04023695 about?
NCT04023695 is a clinical study titled "Trigger Finger Corticosteroid Injection With and Without Local Anesthetic". Steroid injection is the first line treatment for trigger finger. Steroid injection is sometimes mixed with a local anesthetic.
What is the current status of trial NCT04023695?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 110 participants. The study started on 2017-10-01. Estimated completion is 2018-08-30.
What interventions are being tested in trial NCT04023695?
The interventions under investigation include: Corticosteroid with lidocaine with epinephrine (DRUG), Corticosteroid with normal saline (DRUG).
Who is sponsoring clinical trial NCT04023695?
This trial is sponsored by Vanderbilt University Medical Center, which has 677 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04023695's enrollment target sits among peer trials
110 727th of 2000 higher than 1,264 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01530373 · 110 participants · Phase 2
Solifenacin Compared to Clonidine for Reducing Hot Flashes Among Breast Cancer Patients
- NCT02379377 · 110 participants · Phase 1
18F-FSPG PET in Imaging Patients With Liver Cancer Before Undergoing Surgery or Transplant
- NCT02411773 · 110 participants · Phase 1
Sympatholysis in Chronic Kidney Disease
- NCT03190941 · 110 participants · Phase 1
Administering Peripheral Blood Lymphocytes Transduced With a Murine T-Cell Receptor Recognizing the G12V Variant of Mutated RAS in HLA-A*11:01 Patients
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI